Where is BioGX located?

BioGX is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama.

How many employees does BioGX have?

As of Apr 30, 2026, the latest employee count at BioGX is 57.

Is BioGX a funded company?

BioGX is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does BioGX rank among its competitors?

BioGX ranks 421st amongst 684 active competitors, of which 82 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ONCOHOST, which secured $2.8M in May, 2025.

Who are the top competitors of BioGX?

BioGX's top competitors include Strand Life Sciences, BGI and ONCOHOST. Among them, ONCOHOST secured the most recent funding round in May, 2025.

BioGX - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a molecular diagnostic assay for Influenza A, B, and RSV. They offer simple molecular diagnostic options, and they recently declared that their high-performance Sample-ReadyTM PCR assay will be adopted more quickly. The company uses its proprietary platform-agnostic reagent technology to offer products and contract services across a variety of real-time PCR and Next-generation sequencing platforms. It has received CE-IVD markings for its Flu A, Flu B, RSV automated test on Becton,

Website: www.biogx.com/
Social
Registered Address: Birmingham, Alabama

Key Metrics

Founded Year

2007

Location

Birmingham, United States

Stage

Funding Raised

Investors

Innovation Depot

Ranked

421^st among 684 active competitors

Employee Count

57 as on Apr 30, 2026

Similar Companies

Strand Life Sciences & 943 more

View BioGX's full profile

BioGX is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOGX INC CIN: 260197111 , United States, Active	Dec 26, 999	-	50 (As on Dec 31, 2024)	-

BioGX is a funded company. BioGX has 1 institutional investor.

View details of BioGX's funding rounds and investors

The founders of BioGX is Michael Vickery.

Here are the details of BioGX's key team members:

Michael Vickery: CSO, EVP & Founder of BioGX.
Contact Info: 1 email address
Shazi Iqbal: CEO of BioGX.

View details of BioGX's Founder profiles and Board Members

BioGX's employee count trend

BioGX has 57 employees as of Apr 26. Here is BioGX's employee count trend over the years:

Uncover BioGX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioGX include Strand Life Sciences, BGI and ONCOHOST. Here is the list of Top 10 competitors of BioGX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	65/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	64/100
3rd	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	61/100
4th	Souzhou Ribo Life Science 2007, Suzhou (China), Public	Developer of nucleic acid drugs based on RNA interference (RNAi) technology	$201M	Panlin Capital, CICC & 13 others	59/100
5th	deCODE Genetics 1996, Reykjavik (Iceland), Acquired	Provider of a bioinformatics platform for genetic analysis	-	Hercules Capital, Tekla Capital Management ... & 10 others	58/100
6th	PathoQuest 2010, Paris (France), Acquired	Provider of next-generation sequencing for microbiology testing	$9.99M	Kurma Partners, Charles River Laboratories ... & 8 others	57/100
7th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
8th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Ampersand Capital & 5 others	52/100
9th	Axxam 2001, Milan (Italy), Acquired	Provider of services for research application across life sciences industries	-	-	52/100
10th	OraSure 1987, Bethlehem (United States), Public	Provider of point-of-care diagnostic devices for oral fluid specimens	-	Public Health Emergency, Gates & 4 others	52/100
421st	BioGX 2007, Birmingham (United States), Funding Raised	Developer of a molecular diagnostic assay for Influenza A, B, and RSV	-	Innovation Depot	24/100